<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Dig Dis Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Dig. Dis. Sci</journal-id>
      <journal-title-group>
        <journal-title>Digestive Diseases and Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0163-2116</issn>
      <issn pub-type="epub">1573-2568</issn>
      <publisher>
        <publisher-name>Springer US</publisher-name>
        <publisher-loc>Boston</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23918151</article-id>
      <article-id pub-id-type="pmc">3838586</article-id>
      <article-id pub-id-type="publisher-id">2801</article-id>
      <article-id pub-id-type="doi">10.1007/s10620-013-2801-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Extracorporeal Hepatic Resection and Autotransplantation Using Temporary Portocaval Shunt Provides an Improved Solution for Conventionally Unresectable HCC</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wen</surname>
            <given-names>Pei-Hung</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lin</surname>
            <given-names>Kuo-Hua</given-names>
          </name>
          <address>
            <email>120380@cch.org.tw</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Yao-Li</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hsieh</surname>
            <given-names>Chia-En</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ko</surname>
            <given-names>Chih-Jan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuo</surname>
            <given-names>Shou-Jen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Changhua Christian Hospital, Changhua City, Taiwan, ROC </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>8</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>6</day>
        <month>8</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2013</year>
      </pub-date>
      <volume>58</volume>
      <issue>12</issue>
      <fpage>3637</fpage>
      <lpage>3640</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2013</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Extracorporeal hepatic resection</kwd>
        <kwd>Autotransplantation</kwd>
        <kwd>Hepatocellular carcinoma with difficult anatomy</kwd>
        <kwd>Temporary portocaval shunt</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media New York 2013</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>Hepatic resection is the gold-standard treatment for hepatocellular carcinoma (HCC). In East Asia, however, only 20&#xA0;% of patients with HCC are eligible for hepatectomy [<xref ref-type="bibr" rid="CR1">1</xref>]. In a small subset of patients, surgical resection using conventional techniques is extremely challenging. In these marginal cases, the tumor size, extension of the lesion, and proximity of the tumor to critical structures are important factors determining how to proceed. For tumors considered unresectable by conventional means, extracorporeal hepatic resection with autotransplantation (ECHRA) has been proposed to be an alternative [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
    <p>ECHRA has been used to treat hepatic pathologies including giant hemangioma [<xref ref-type="bibr" rid="CR3">3</xref>], liver metastases [<xref ref-type="bibr" rid="CR4">4</xref>], and sarcomas [<xref ref-type="bibr" rid="CR2">2</xref>]. However, few studies have reported on its application as a treatment for HCC [<xref ref-type="bibr" rid="CR5">5</xref>]. Herein we report a case series involving three consecutive patients with HCC who were successfully treated with ECHRA as curative therapy for otherwise unresectable HCCs.</p>
    <sec id="Sec1">
      <title>Patient Selection and Pre-operative Evaluation</title>
      <p>In 2011, ECHRA was performed in three patients with liver tumors at anatomically critical locations that were deemed technically impossible to resect (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Patient characteristics and indications for this technique are outlined in Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>. To ensure sufficient liver function after liver resection, we estimated pre- and post-operative liver volumes using 3-D computed tomography volumetry. Indocyanine green (ICG) test was performed in selected patients. None of the patients showed evidence of portal hypertension.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>CT images of case series. <bold>a</bold> Large liver tumor with compression of the IVC (<italic>arrow</italic>), left hepatic vein and right hepatic vein. The middle hepatic vein has been obscured. The resection line (<italic>white line</italic>) follows the left hepatic vein. <bold>b</bold> Both the portal vein (<italic>navy blue</italic>) and IVC (<italic>dark blue</italic>) are compressed by the tumor. The resection line in this view follows the left portal vein. <bold>c</bold> Coronal illustration of the resection line (<italic>white line</italic>)</p></caption><graphic xlink:href="10620_2013_2801_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Patient characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient characteristics</th><th align="left">Patient 1</th><th align="left">Patient 2</th><th align="left">Patient 3</th></tr></thead><tbody><tr><td align="left">Age</td><td align="left">67</td><td align="left">71</td><td align="left">60</td></tr><tr><td align="left">Sex</td><td align="left">M</td><td align="left">M</td><td align="left">M</td></tr><tr><td align="left">ECOG</td><td align="left">0</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left" colspan="4">Pre-operative data</td></tr><tr><td align="left">&#xA0;Hepatitis history</td><td align="left">Non-B/C, alcoholism</td><td align="left">Hepatitis B</td><td align="left">Hepatitis C</td></tr><tr><td align="left">&#xA0;AFP (ng/ml)</td><td align="left">357.59</td><td align="left">&gt;270,000</td><td align="left">24.25</td></tr><tr><td align="left">&#xA0;Platelet count (/&#x3BC;l)</td><td align="left">227&#xA0;&#xD7;&#xA0;10<sup>3</sup>
</td><td align="left">335&#xA0;&#xD7;&#xA0;10<sup>3</sup>
</td><td align="left">380&#xA0;&#xD7;&#xA0;10<sup>3</sup>
</td></tr><tr><td align="left">&#xA0;INR</td><td align="left">1.22</td><td align="left">1.28</td><td align="left">0.93</td></tr><tr><td align="left">&#xA0;Evidence of PH</td><td align="left">No</td><td align="left">No</td><td align="left">No</td></tr><tr><td align="left" colspan="4">Tumor characteristics</td></tr><tr><td align="left">&#xA0;Maximum diameter (cm)</td><td align="left">18&#xA0;&#xD7;&#xA0;12</td><td align="left">18&#xA0;&#xD7;&#xA0;13</td><td align="left">5.8&#xA0;&#xD7;&#xA0;6.8</td></tr><tr><td align="left">&#xA0;Tumor location</td><td align="left">S 1, 4, 5, 7, 8</td><td align="left">S 2, 3, 4, 5, 8</td><td align="left">S 4, 5, 8;<break/>Satellite S7</td></tr><tr><td align="left">Indication for ECHRA (vascular involvement/tumor location)</td><td align="left">At confluence of LHV, MHV, IVC</td><td align="left">At confluence of V7/RHV into IVC</td><td align="left">Centrally located, involve RHV, PV</td></tr><tr><td align="left">Remnant liver volume (%)<sup>a</sup>
</td><td align="left">44.26</td><td align="left">34.46</td><td align="left">51.00</td></tr></tbody></table><table-wrap-foot><p>
<italic>ECOG</italic> Eastern Cooperative Oncology Group performance status, <italic>PH</italic> portal hypertension, <italic>S</italic> liver segment, <italic>LHV</italic> left hepatic vein, <italic>MHV</italic> middle hepatic vein, <italic>IVC</italic> inferior vena cava, <italic>V7</italic> hepatic vein to segment 7, <italic>RHV</italic> right hepatic vein, <italic>PV</italic> portal vein</p><p>
<sup>a</sup>Ratio of remnant liver volume and standard liver volume</p></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="Sec2">
      <title>Surgery</title>
      <p>ECHRA was performed as described previously with minor modifications [<xref ref-type="bibr" rid="CR6">6</xref>]. Unlike previous reports, we employed temporary portocaval shunt during the anhepatic period (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). In patients with tumor-invaded major vasculature, the vessel wall was pared and reconstruction with a venous patch harvested from the explanted liver (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Details of the surgery are given in Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>. The affected segments of liver were resected after total hepatectomy and the autograft was re-implanted orthotopically. Pathology evaluation confirmed all three tumors to be HCC.<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>
<bold>a</bold> Temporary portocaval shunt used during the anhepatic period. <bold>b</bold> Tumor thrombus found in the confluence of the hepatic veins. <bold>c</bold> Re-implantation of the graft</p></caption><graphic xlink:href="10620_2013_2801_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>
<bold>a</bold> Large HCC compressing the juncture of left hepatic vein and IVC. <bold>b</bold> Part of the IVC wall was excised and repaired with a venous patch (<italic>arrow</italic>). <bold>c</bold> Unification of V7 and right hepatic vein, which was later widened with a venous patch</p></caption><graphic xlink:href="10620_2013_2801_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Operation characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Operation (OP) details</th><th align="left">Patient 1</th><th align="left">Patient 2</th><th align="left">Patient 3</th></tr></thead><tbody><tr><td align="left">Replanted graft segments</td><td align="left">S 2, 3, and partial S 4</td><td align="left">S 5&#x2013;8</td><td align="left">S 2, 3, and S 6, 7</td></tr><tr><td align="left">Graft weight (g)</td><td align="left">440</td><td align="left">696</td><td align="left">961</td></tr><tr><td align="left">Blood loss (ml)</td><td align="left">1,500</td><td align="left">5,300</td><td align="left">7,000</td></tr><tr><td align="left">Cold ischemic time (min)</td><td align="left">120</td><td align="left">202</td><td align="left">162</td></tr><tr><td align="left">Warm ischemic time (min)</td><td align="left">40</td><td align="left">14</td><td align="left">43</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec3">
      <title>Results and Outcome</title>
      <p>The outcomes are outlined in Table&#xA0;<xref rid="Tab3" ref-type="table">3</xref>. Patient 3 had major complications included postoperative biliary leakage and intra-abdominal abscess, which were treated with endoscopic retrograde cholangiopancreatography and surgical drainage of the abscess, respectively. There was no hospital mortality.<table-wrap id="Tab3"><label>Table&#xA0;3</label><caption><p>Postoperative data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Post-op data</th><th align="left">Patient 1</th><th align="left">Patient 2</th><th align="left">Patient 3</th></tr></thead><tbody><tr><td align="left">ICU days (days)</td><td align="left">8</td><td align="left">7</td><td align="left">8</td></tr><tr><td align="left">Length of stay (days)</td><td align="left">30</td><td align="left">22</td><td align="left">39</td></tr><tr><td align="left">Ishak score</td><td align="left">3</td><td align="left">3</td><td align="left">4</td></tr><tr><td align="left">Metavir fibrosis score</td><td align="left">F2</td><td align="left">F2</td><td align="left">F3</td></tr><tr><td align="left">Post-op complication</td><td align="left">1. Sepsis<break/>2. Transient hepatic insufficiency</td><td align="left">1. Sepsis<break/>2. Transient hepatic insufficiency</td><td align="left">1. Sepsis<break/>2. Transient hepatic insufficiency<break/>3. Biliary leakage<break/>4. Intra-abdominal abscess</td></tr><tr><td align="left">&#xA0;Intervention</td><td align="left">None</td><td align="left">None</td><td align="left">ERCP for biliary leakage</td></tr><tr><td align="left">&#xA0;Reoperation</td><td align="left">None</td><td align="left">None</td><td align="left">Laparotomy for drainage of abscess</td></tr><tr><td align="left" colspan="4">Long-term follow-up</td></tr><tr><td align="left">&#xA0;Recurrence</td><td align="left">None</td><td align="left">In post-op 8&#xA0;month</td><td align="left">In post-op 8&#xA0;month</td></tr><tr><td align="left">&#xA0;Management for recurrence</td><td align="left">None</td><td align="left">RFA</td><td align="left">TACE</td></tr><tr><td align="left">&#xA0;Current status</td><td align="left">Alive (28&#xA0;months)</td><td align="left">Alive (26&#xA0;months)</td><td align="left">Alive (23&#xA0;months)<sup>a</sup>
</td></tr></tbody></table><table-wrap-foot><p>
<italic>RFA</italic> radiofrequency ablation, <italic>TACE</italic> transarterial chemoembolization</p><p>
<sup>a</sup>Alive until May, 2013</p></table-wrap-foot></table-wrap></p>
      <p>Two of the three patients experienced tumor recurrence 8&#xA0;months after the operation. Patient 2 was treated with radiofrequency ablation while the other was treated by transarterial chemoembolization. All patients are currently alive with stable disease at the most recent follow-up.</p>
      <p>To date, the only large series involving ECHRA was reported by Oldhafer et al. [<xref ref-type="bibr" rid="CR7">7</xref>]. The difficulty of the surgical technique and the high perioperative and postoperative morbidity impede surgeons from using this procedure. We are the first institution to use preoperative liver volumetry to prevent postoperative hepatic failure, the most serious complication. The preoperative evidence of preserved liver function and without liver cirrhosis or portal hypertension were other determinants for a good outcome. The three patients did well after the operation. In the literature reporting patients with HCC receiving ECRHA, our first patient had the longest survival [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
      <p>Unlike other studies, we used a temporary portocaval shunt instead of venovenous bypass to facilitate hemodynamic stability during the anhepatic period. Temporary portocaval shunts have been shown to improve hemodynamic status, reduce requirement of intraoperative blood transfusion, and preserve renal function during orthotopic liver transplantation [<xref ref-type="bibr" rid="CR8">8</xref>]; however, it has not been reported to be used in ECHRA. We believed that the relatively short cold ischemic time and preservation of the inferior vena cava enhanced the functionality of the temporary portocaval shunt during the anhepatic period.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>ECHRA represents an additional surgical option in the treatment of unresectable hepatic tumors, including HCC. In addition, the use of a temporary portocaval shunt is a feasible alternative to venovenous bypass during the anhepatic period.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris-Stiff</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>de Liguori Carino</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Prasad</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Surgical management of hepatocellular carcinoma: is the jury still out?</article-title>
          <source>Surg Oncol</source>
          <year>2009</year>
          <volume>18</volume>
          <fpage>298</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="doi">10.1016/j.suronc.2008.08.003</pub-id>
          <pub-id pub-id-type="pmid">19062271</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruttadauria</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marsh</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Bartlett</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Gridelli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Marcos</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ex situ resection techniques and liver autotransplantation: last resource for otherwise unresectable malignancy</article-title>
          <source>Dig Dis Sci</source>
          <year>2005</year>
          <volume>50</volume>
          <fpage>1829</fpage>
          <lpage>1835</lpage>
          <pub-id pub-id-type="doi">10.1007/s10620-005-2946-5</pub-id>
          <pub-id pub-id-type="pmid">16187182</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ikegami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Soejima</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Taketomi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracorporeal hepatic resection for unresectable giant hepatic hemangiomas</article-title>
          <source>Liver Transpl</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>115</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="doi">10.1002/lt.21272</pub-id>
          <pub-id pub-id-type="pmid">18161765</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hemming</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Cattral</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Ex vivo liver resection with replacement of the inferior vena cava and hepatic vein replacement by transposition of the portal vein</article-title>
          <source>J Am Coll Surg</source>
          <year>1999</year>
          <volume>189</volume>
          <fpage>523</fpage>
          <lpage>526</lpage>
          <pub-id pub-id-type="doi">10.1016/S1072-7515(99)00192-1</pub-id>
          <pub-id pub-id-type="pmid">10549741</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugimachi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shirabe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taketomi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Successful curative extracorporeal hepatic resection for far-advanced hepatocellular carcinoma in an adolescent patient</article-title>
          <source>Liver Transpl</source>
          <year>2010</year>
          <volume>16</volume>
          <fpage>685</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="pmid">20440778</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pichlmayr</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Grosse</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hauss</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gubernatis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lamesch</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bretschneider</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver</article-title>
          <source>Br J Surg</source>
          <year>1990</year>
          <volume>77</volume>
          <fpage>21</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="doi">10.1002/bjs.1800770107</pub-id>
          <pub-id pub-id-type="pmid">2302506</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oldhafer</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schlitt</surname>
              <given-names>HJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term experience after ex situ liver surgery</article-title>
          <source>Surgery</source>
          <year>2000</year>
          <volume>127</volume>
          <fpage>520</fpage>
          <lpage>527</lpage>
          <pub-id pub-id-type="doi">10.1067/msy.2000.105500</pub-id>
          <pub-id pub-id-type="pmid">10819060</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Figueras</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Llado</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study</article-title>
          <source>Liver Transpl</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>904</fpage>
          <lpage>911</lpage>
          <pub-id pub-id-type="doi">10.1053/jlts.2001.27870</pub-id>
          <pub-id pub-id-type="pmid">11679990</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
